Management of Inferior STEMI with Conduction Abnormalities

Initial Assessment and Stabilization

The European Society of Cardiology recommends immediate activation of a "fast-track" system with transfer to the catheterization laboratory for primary PCI within 90 minutes of first medical contact, along with continuous cardiac monitoring due to the inferior wall STEMI with evidence of conduction abnormality (2.5-second pause) 1, 2
The European Heart Journal suggests immediately initiating continuous ECG monitoring to detect further arrhythmias or conduction disturbances, as the 2.5-second pause indicates potential for more serious conduction abnormalities 3, 2
Administer oxygen only if the patient is hypoxemic (SaO₂ < 90% or PaO₂ < 60 mmHg), as routine oxygen is not recommended when SaO₂ ≥ 90%, according to the European Heart Journal 1
Provide pain relief with titrated intravenous opioids (morphine), recognizing that this may slow the uptake of oral antiplatelet agents, as recommended by the European Heart Journal 1
Obtain 12-lead ECG confirmation of the inferior STEMI (ST elevation in leads II, III, AVF), as suggested by the European Heart Journal 4, 5

The American College of Cardiology recommends administering aspirin 160-325 mg orally immediately 7
Administer a P2Y12 inhibitor (ticagrelor or prasugrel preferred over clopidogrel if no contraindications), as recommended by the European Heart Journal 1
Initiate anticoagulation with unfractionated heparin, enoxaparin, or bivalirudin according to local protocol, as suggested by the European Heart Journal 1

Alert the cardiac catheterization laboratory for immediate primary PCI, which should be performed within 90 minutes of first medical contact, as recommended by the European Heart Journal 5, 1
For patients with inferior STEMI and conduction abnormalities, primary PCI is strongly preferred over fibrinolysis when available within the recommended timeframe, according to the European Heart Journal 1, 6

The European Heart Journal suggests that the 2.5-second pause requires close monitoring as it may indicate sinoatrial node dysfunction or developing heart block, which is common in inferior wall infarctions 3, 2
Have transcutaneous pacing capabilities immediately available, as recommended by the European Heart Journal 6
If bradycardia is symptomatic or hemodynamically significant, administer atropine 0.5-1.0 mg IV (may repeat to a maximum of 3 mg), as suggested by the European Heart Journal 1, 6

Monitor for right ventricular involvement, which occurs in up to 40% of inferior wall MIs and may require specific management (fluid administration, avoiding nitrates), as recommended by the European Heart Journal 6
Watch for signs of cardiogenic shock, which would require additional hemodynamic support, as suggested by the European Heart Journal 6
Perform echocardiography to assess ventricular function and rule out mechanical complications, as recommended by the European Heart Journal 1, 6

Avoid nitrates in patients with inferior STEMI with suspected right ventricular involvement as they can cause profound hypotension, as warned by the European Heart Journal 6
Avoid excessive fluid administration in patients without right ventricular involvement as it may worsen left ventricular failure, as cautioned by the European Heart Journal 6
Do not delay reperfusion therapy while waiting for cardiac biomarker results when ECG shows clear ST-segment elevation, as recommended by the European Heart Journal 5, 1
Be cautious with beta-blockers and calcium channel blockers in the setting of conduction abnormalities, as they may worsen bradycardia or heart block, as warned by the European Heart Journal 6